China's drug regulator accepted the addition of severe acute pancreatitis as an indication for Beijing Hotgen Biotech (SHA:688068) subsidiary Beijing Shunjing Biopharmaceutical Technology's SGC001 injection.
The drug is also indicated for acute myocardial infarction, according to a Tuesday filing with the Shanghai bourse.
One MobiKwik Systems (NSE:MOBIKWIK, BOM:544305) said it has received in-principle approval from the Reserve Bank of India for a Payment Aggregator-Physical (PA-P) license, according to an Indian bourse filing on Tuesday.The approval will allow the company to expand its offline merchant payments business across India, the filing said. MobiKwik currently serves 4.9 million merchants through products including UPI QR, soundbox and EDC machines, it added.The company said it will focus on small businesses, fuel outlets and organized retail over the next 18-24 months as it looks to increase market share in offline merchant payments.Shares of the digital payments company jumped over 6% in recent trade.
Jiayou International Logistics (SHA:603871) plans to repurchase shares worth between 50 million yuan and 100 million yuan, according to a Shanghai bourse filing on Tuesday.The share buyback will be made within three months after the board of directors' approval.Each share will be bought for up to 19.47 yuan.
Juheshun New Material (SHA:605166) fully redeemed a 10.5 million yuan structured deposit, according to a Shanghai bourse filing on Tuesday.Aside from the redeemed funds, the company also received returns amounting to 3,600 yuan.The wealth management product was bought on April 24.The electronic appliances manufacturer's shares dropped by over 3% at the close.